344 related articles for article (PubMed ID: 24188566)
1. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation.
Barnett AN; Manook M; Nagendran M; Kenchayikoppad S; Vaughan R; Dorling A; Hadjianastassiou VG; Mamode N
Transpl Int; 2014 Feb; 27(2):187-96. PubMed ID: 24188566
[TBL] [Abstract][Full Text] [Related]
2. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
[TBL] [Abstract][Full Text] [Related]
3. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic apheresis in ABO-incompatible kidney and liver transplantation: A single-center experience of 50 patients.
Pandey P; Setya D; Sinha V; Bhatt A; Devra A; Chaudhary A; Ranjan S; Srivastava R; Kumar P; Singh MK
Ther Apher Dial; 2021 Feb; 25(1):103-117. PubMed ID: 32266793
[TBL] [Abstract][Full Text] [Related]
5. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
7. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
[TBL] [Abstract][Full Text] [Related]
8. Isoagglutinin adsorption in ABO-incompatible transplantation.
Genberg H; Kumlien G; Wennberg L; Tydén G
Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
Becker LE; Siebert D; Süsal C; Opelz G; Leo A; Waldherr R; Macher-Goeppinger S; Schemmer P; Schaefer SM; Klein K; Beimler J; Zeier M; Schwenger V; Morath C
Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of rituximab dosage for ABO-incompatible living-donor kidney transplantation.
Nakao T; Ushigome H; Kawai K; Nakamura T; Harada S; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
Transplant Proc; 2015 Apr; 47(3):644-8. PubMed ID: 25891703
[TBL] [Abstract][Full Text] [Related]
12. Vienna experience of ABO-incompatible living-donor kidney transplantation.
Haidinger M; Schmaldienst S; Körmöczi G; Regele H; Soleiman A; Schwartz D; Derfler K; Steininger R; Mühlbacher F; Böhmig GA
Wien Klin Wochenschr; 2009; 121(7-8):247-55. PubMed ID: 19562281
[TBL] [Abstract][Full Text] [Related]
13. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
[TBL] [Abstract][Full Text] [Related]
14. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation.
Ishida H; Kondo T; Shimizu T; Nozaki T; Tanabe K
Transpl Int; 2015 Mar; 28(3):286-96. PubMed ID: 25363583
[TBL] [Abstract][Full Text] [Related]
15. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
17. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
Sugiyama K; Hyodo Y; Aikawa A
Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
[TBL] [Abstract][Full Text] [Related]
19. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
[TBL] [Abstract][Full Text] [Related]
20. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
